Volume 2 Number 2
Editorial
Working Group 10 column
26
Percutaneous coronary intervention for bifurcation disease. A consensus view from the first meeting of the European Bifurcation ClubThomas M, Hildick-Smith D, Louvard Y, Albiero R, Darremont O, Stankovic G, Pan M, Legrand V, de Bruyne B, Lefčvre T
EuroInterv.2006;2:149-153
Expert review
27
The inoperable valvular heart disease patient: the pluses and minuses of percutaneous valvular replacementEuroInterv.2006;2:154-160
Clinical research
28
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trialHolmes DR, Coolong A, O'Shaughnessy C, Chauhan M, van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma J, Cutlip D, Kuntz R, Cardioshield Application Protects during Transluminal Intervention of Vein grafts by reducing Emboli (CAPTIVE) trial investigators
EuroInterv.2006;2:161-168
29
Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructionsEuroInterv.2006;2:169-174
30
Sex differences and their impact on clinical outcome after percutaneous or surgical revascularisation: a report from the Arterial Revascularization Therapies Study (ARTS).Voudris V, Ong ATL, Serruys PW, Sianos G, Stavrides G, Lindeboom W, Cokkinos D, on behalf of the Arterial Revascularisation Therapy Study (ARTS) Investigators
EuroInterv.2006;2:175-180
31
Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approachEuroInterv.2006;2:181-186
32
Real world experience with TITAN® stent: a 9-month follow-up report from The Titan PORI RegistryEuroInterv.2006;2:187-191
33
The Titanium-NO Stent: results of a multicentre registryMosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Jeffery J, Guetta V, Solomon M, Lotan C
EuroInterv.2006;2:192-196
34
Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcomeGómez-Moreno S, Sabaté M, Jiménez-Quevedo P, Vázquez P, Alfonso F, Angiolillo D, Hernández-Antolín R, Moreno R, Bańuelos C, Escaned J, Macaya C
EuroInterv.2006;2:197-202
35
N-terminal pro-brain natriuretic peptide level in relation to epicardial and myocardial reperfusion in ST-segment elevation myocardial infarction treated with facilitated angioplastyEuroInterv.2006;2:203-210
36
Intracoronary nicorandil prior to reperfusion in acute myocardial infarctionMiyazawa A, Ikari Y, Tanabe K, Nakajima H, Aoki J, Iijima R, Nakayama T, Hatori M, Nakazawa G, Tanimoto S, Onuma Y, Hara K
EuroInterv.2006;2:211-217
37
Clinical and angiographic follow-up after overlapping implantation of polytetrafluoroethylene covered stents with drug eluting stentsPapafaklis M, Sianos G, Cost B, Vaina S, Manginas A, Dardas P, Tsikaderis D, van Mieghem CAG, Michalis L, Serruys PW
EuroInterv.2006;2:218-223
38
Myocardial perfusion scintigraphy to predict outcomes after coronary stentingZalc S, Ambrose J, Lemos P, Ribeiro E, Soares Jr. J, Giorgi M, Esteves-Filho A, Horta P, Meneghetti J, Ramires J, Martinez E
EuroInterv.2006;2:224-230
39
Low incidence of cardiac biomarker elevation following PCI of chronic total coronary occlusionsEuroInterv.2006;2:231-237
40
The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosisEuroInterv.2006;2:238-243
41
Histopathology of material captured by embolic protection device after percutaneous coronary interventions in atherosclerotic saphenous vein graftEuroInterv.2006;2:244-249
Experimental research
42
Shear stress is associated with markers of plaque vulnerability and MMP-9 activityKrams R, Cheng C, Helderman F, Verheye S, van Damme LCA, Mousavi Gourabi B, Tempel D, Segers D, de Feyter PJ, Pasterkamp G, De Klein D, de Crom R, van der Steen A, Serruys PW
EuroInterv.2006;2:250-256
Special report
43
First case of combined percutaneous aortic valve replacement and coronary artery revascularisationEuroInterv.2006;2:257-261
Technical report
44
Principles of a self contained catheterisation laboratory based intravascular magnetic resonance systemEuroInterv.2006;2:262-264
45
Small 0.7 mm diameter laser catheter for chronic total occlusions, small vessels, tortuous anatomy, and balloon-resistant lesions - development and initial experienceEuroInterv.2006;2:265-269
Image in cardiology
47
Acute myocardial infarction due to spontaneous coronary artery dissection detected three days before by 64-slice spiral computed tomographyEuroInterv.2006;2:272
Volume 2 Number 2 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Cordis, a Johnson & Johnson company
- GE Healthcare
- Hexacath
- Medtronic
- Terumo



